The ALL Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

About the ALL Hub

The ALL Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education on acute lymphoblastic leukemia (ALL). Our aim is to enhance knowledge in ALL, through the multichannel dissemination of global advances related to its classification, diagnosis, treatment, and management.
The ALL Hub shares new data, evidence-based articles, therapy approvals, expert opinions, and international congress coverage to treatment teams and researchers around the world.


For every treatment team and researcher to have instant access to expert opinions and the latest evidence-based information in ALL, to aid in treatment decisions and improve the lives of patients with ALL globally.


Enhance the collective knowledge base in ALL through global multichannel dissemination of the most up-to-date evidence-based information in ALL, to help inform on disease management and treatment strategies.


The ALL Hub was founded in partnership with the European School of Haematology (ESH). ESH is a not-for-profit institution for the dissemination of information and lifelong learning founded in 1985 to promote and facilitate access to state-of-the-art and cutting-edge knowledge in hematology and related disciplines at the European level. ESH conferences present state-of-the-art science and insight into new developments in the fields of basic, clinical, and therapeutic research in hematology.

The Scientific Education Support Team